Gastric Carcinoma: potential oncogene (upregulation of miR650 and EMT) (Liu et al., 2021); potential tumor suppressor (upregulation of its PBXIP1 inhibitor) (He et al., 2017). This evidence concerns the gene PBXIP1 and neoplasm.